Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your experience. Save up to 40% More details

Abortion pills over the counter? Experts see big hurdles in widening U.S. access

World Jun 24, 2022 06:21PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
© Reuters. FILE PHOTO: A pill of Misoprostol, used to terminate early pregnancies, is displayed in a pharmacy in Provo, Utah, U.S. May 12, 2022. REUTERS/George Frey

By Ahmed Aboulenein

WASHINGTON (Reuters) -A pill used to terminate early pregnancies is unlikely to become available without a prescription for years, if ever, experts told Reuters, as the conservative-leaning U.S. Supreme Court dramatically curbed abortion rights this week.

The Supreme Court on Friday overturned the landmark 1973 Roe v. Wade ruling that recognized the constitutional right to an abortion and legalized it nationwide. The new ruling stung abortion rights advocates and was a momentous victory to Republicans and religious conservatives.

The pill, mifepristone, in combination with a second drug called misoprostol, induces an abortion up to 10 weeks into a pregnancy and is only available through a certified doctor's prescription. Abortion rights activists have stepped up calls to make it available at pharmacies without a prescription.

Many U.S. states intend to severely limit or outright ban abortions after the ruling. The White House is considering options to increase access to so-called medication abortions, which can be administered at home.

"Today I am directing the Department of Health and Human Services to take steps to ensure these critical medications are available to the fullest extent possible," President Joe Biden said at the White House on Friday.

"We will double down and use every lever we have to protect access to abortion care," Secretary of Health and Human Services Xavier Becerra said in a statement, adding the department would ensure access to "medication abortion that has been approved by the FDA for over 20 years."

Neither Biden nor Becerra addressed making the pills available over-the-counter, a process that could take years, medical and regulatory experts told Reuters. They said drugmakers would need to conduct studies showing directions on the product's packaging would enable a consumer to safely use it without professional medical guidance.

    The two companies that make the pill for the U.S. market have shown no interest in the process. Should they do, any U.S. Food and Drug Administration approval would become a target for lawsuits from abortion opponents that could delay implementation for years, experts said.

     "The hard part that I see is getting the evidence or the agreement that no prescriber is needed at all," said Susan Wood, a former Assistant Commissioner for Women's Health at the FDA.

    "I personally don't see it happening in the next couple of years," said Wood, now director of George Washington University's Jacobs Institute of Women's Health.


    Access to abortion pills is expected to become the next big battle, as their use is harder to track. The FDA has already relaxed some restrictions, making it easier for certified doctors to prescribe them.

It now allows certified doctors to prescribe mifepristone after a telehealth visit rather than in-person. Patients can receive it by mail, making it easier for women in states that restrict its use.

The White House has considered making abortion pills available online and from pharmacies abroad, with a prescription. However, the import possibility has been curtailed by Congress in broader legislation about drug regulation.

    An over-the-counter designation would make it much easier to access pills in states restricting their use. For example, they could more easily be mailed from a friend or supporter in a state where they are not banned.

The FDA declined to comment on whether over-the-counter use of abortion pills has been considered. A spokesperson for Danco Laboratories, a manufacturer of mifepristone, said it does not plan to seek over-the-counter approval. GenBioPro, the second maker of mifepristone for the U.S. market, did not respond to requests for comment.


Medication abortion involves two drugs, taken over a day or two. The first, mifepristone, blocks the pregnancy-sustaining hormone progesterone. The second, misoprostol, induces uterine contractions.

When taken together, they halt the pregnancy and prompt cramping and bleeding to empty the uterus, a process similar to miscarriage.

    Abortion rights activists say the pills have a long track record of being safe and effective, with no risk of overdose or addiction. In several countries, including India and Mexico, women can buy them without a prescription to induce abortion.

    "Medication abortion really does meet all the FDA criteria for an over-the-counter switch," said Antonia Biggs, associate professor at the University of California, San Francisco's Obstetrics, Gynecology and Reproductive Sciences department.

Sue Liebel, state policy director for anti-abortion group Susan B. Anthony List, argued the FDA put women at risk by relaxing restrictions on mifepristone.

"Going over-the-counter would be the most egregious action we've ever seen the FDA do," she said. "If that does happen, we would certainly want to try to litigate that."

FDA records show an extremely small mortality case number: As of June 2021, there were reports of 26 deaths associated with mifepristone out of 4.9 million people estimated to have taken the pill since the product was approved in September 2000.

    A study by Biggs and colleagues found that the majority of participants would understand a medication abortion over-the-counter label. Biggs said she was not in talks with drugmakers over her research.

    Others point to the decade-long legal fight for over-the-counter Plan B, a form of emergency contraception taken within days of sexual intercourse. The FDA approved its use for women 18 and over in 2006 and for all women in 2013.

    "There was very strong support that you did not need a prescriber," said Wood, who resigned from the FDA in 2005 over the delay.

    "Everybody under the sun agreed except for a small group of people who somehow had an enormous political influence."

Abortion pills over the counter? Experts see big hurdles in widening U.S. access

Related Articles

Russian forces pound Ukraine's Donetsk region
Russian forces pound Ukraine's Donetsk region By Reuters - Aug 15, 2022

By Natalia Zinets KYIV (Reuters) - Ukrainian forces reported heavy Russian shelling and attempts to advance on several towns in the eastern region of Donetsk that has become a key...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at’s discretion.

Write your thoughts here
Are you sure you want to delete this chart?
Post also to:
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Are you sure you want to delete this chart?
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
Sign up with Email